FALLOPIAN TUBE CANCERS
Clinical trials for FALLOPIAN TUBE CANCERS explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CANCERS trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to fight advanced ovarian cancer before surgery
Disease control Recruiting nowThis study tests whether adding an experimental drug called TORL-1-23 to standard chemotherapy before surgery can help women with advanced ovarian cancer. About 60 participants with a specific tumor marker (CLDN6) will receive the combination, then undergo surgery. The goal is to…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE1, PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug aimed at Hard-to-Treat ovarian cancer shows promise in trial
Disease control Recruiting nowThis study tests a drug called mirvetuximab soravtansine (MIRV) in people with ovarian, peritoneal, or fallopian tube cancer that no longer responds to platinum chemotherapy and has high levels of a protein called FRα. The drug delivers a cancer-killing agent directly to tumor ce…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New combo aims to stop ovarian Cancer's return
Disease control Recruiting nowThis study tests whether a PARP inhibitor combined with bevacizumab (Avastin) can delay cancer recurrence in people with advanced ovarian, fallopian-tube, or primary peritoneal cancer that has a specific DNA repair defect (HRD). About 120 participants will receive chemotherapy pl…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE2, PHASE3 • Sponsor: N.N. Alexandrov National Cancer Centre • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC